Newer developments however, have brought attention to HDAC-inhibitors in other applications, for instance to treat HIV infections, muscular dystrophies, inflammatory diseases, as well as neurodegenerative diseases, such as Alzheimer’s Disease, frontotemporal dementia and Friedreich's ataxia [81]. The gene discussed is HDAC9; the disease is early-onset autosomal dominant Alzheimer disease.